arrow
Back
C

Catherine Thiéblemont

universite paris cite

100H-index
886Paper Count
3.6WCitation Count
Published Papers 192
Publication Date
Correction: Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?
err2026-03-02
err0
errOAAI
errMarta Canelo-Vilaseca; Mohamad Sabbah; Caterina Cristinelli; Côme Bommier; Pierre Sesques; Mikael Roussel; Pierre Bories; Vincent Allain; Amani Ouedrani; Ilenia De Bernardis; Agathe Vely; Pierre Stephan; Laetitia Vercellino; Fabienne Venet; Rémi Pescarmona; Roch Houot; François Vergez; Romain de Jorna; Isabelle Madelaine; Nathalie Parquet; Anne C. Brignier; Jérôme Larghero; Miryam Mebarki; Roberta Di Blasi; Sophie Caillat-Zucman; Catherine Thieblemont
errShare
errSave
Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?
err2026-01-08
err0
errOAAI
errMarta Canelo-Vilaseca; Mohamad Sabbah; Caterina Cristinelli; Bommier Côme; Pierre Sesques; Mikael Roussel; Pierre Bories; Vincent Allain; Amani Ouedrani; Ilenia De Bernardis; Agathe Vely; Pierre Stephan; Laetitia Vercellino; Fabienne Venet; Rémi Pescarmona; Roch Houot; François Vergez; Romain de Jorna; Isabelle Madelaine; Nathalie Parquet; Anne C. Brignier; Jérôme Larghero; Miryam Mebarki; Di Blasi Roberta; Sophie Caillat-Zucman; Catherine Thieblemont
errShare
errSave
Outcome of Patients with Mantle Cell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy: A Descar-T Study By Lysa Group
err2025-10-03
err0
errOAAI
errMarion Aymard; Morgane Cheminant; Roch Houot; Anne Cuozzo; Elodie Gat; Catherine Thieblemont; Laure Ricard; Louise Roulin; Krimo Bouabdallah; Violaine Safar; Stephanie Guidez; Amandine Fayard; Gabriel Brisou; Loic Ysebaert; Olivier Hermine; Benoît Tessoulin; Charles Herbaux; Steven Le Gouill; Clementine Sarkozy
errShare
errSave
PROs versus clinician-reported adverse events in a large clinical trial: findings from the Phase 3 POLARIX study
errBlood
IF23.1
err2025-09-29
err0
errOAAI
errCarrie Thompson; Marek Trněný; Franck Morschhauser; Gilles Salles; Patrick M. Reagan; Mark Hertzberg; Huilai Zhang; Catherine Thieblemont; Bei Hu; Gustavo Fonseca; Won Seog Kim; Maurizio Martelli; Amitkumar Mehta; Avrita Singh; Mark Yan; Jamie Hirata; Matthew Sugidono; Calvin Lee; Jeff P. Sharman; Neha Mehta-Shah; Christopher R. Flowers; Hervé Tilly; Neil Chua; René-Olivier Casasnovas; Fiona Miall; Tae Min Kim; Xavier Cheng-Hong Tsai; Sunita Nasta; Seung Tae Lee; Jonathan W. Friedberg
errShare
errSave
Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up
err2025-09-23
err0
errOAAI
errCatherine Thieblemont; Maria Gomes Da Silva; Sirpa Leppä; Georg Lenz; Anne-Ségolène Cottereau; Christopher Fox; Armando Lopez-Guillermo; Timothy Illidge; Wojciech Jurczak; Hans Eich; Igor Aurer; Marek Trneny; Andy Andreas Rosenwald; Andrew Davies; Ben (Gerben) Zwezerijnen; Natacha Bolanos; Maja Marković; Jean-Philippe Jais; Florence Broussais; Martin Dreyling; Umberto Vitolo; Hervé Tilly; Marie-José Kersten
errShare
errSave
Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe
err2025-09-23
err0
errOAAI
errFlorence Broussais; Elise Pennings; Natacha Bolanos; Lorna Warwick; Robin Doeswijk; Gauthier Quinonez; Andrii Lebeda; Maria Gomes Da Silva; Sirpa Leppä; Georg Lenz; Anne-Ségolène Cottereau; Christopher Fox; Armando Lopez-Guillermo; Timothy Illidge; Wojciech Jurczak; Hans Eich; Igor Aurer; Marek Trneny; Andy Andreas Rosenwald; Andrew Davies; Ben (Gerben) Zwezerijnen; Jean-Philippe Jais; Martin Dreyling; Umberto Vitolo; Hervé Tilly; Catherine Thieblemont; Marie Jose Kersten
errShare
errSave
Routine Prophylaxis with Levetiracetam offers no benefit in CD19 CAR-T for LBCL: a Multicenter Propensity-matched Study
err2025-08-11
err0
errOAAI
errEugenio Galli; Roberta Di Blasi; Alice Di Rocco; Caterina Cristinelli; Ilaria Pansini; Côme Bommier; Alessandro Corrente; Ilenia De Bernardis; Marcello Viscovo; Stefan Hohaus; Anna Modoni; Federica Sorà; Patrizia Chiusolo; Maurizio Martelli; Simona Sica; Catherine Thieblemont
errShare
errSave
Brentuximab Vedotin addition to Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphoma: a LYSA Phase II Study
err2025-08-06
err0
errOAAI
errOlivier Tournilhac; Kamal Bouabdallah; Solene Lecolant; Maya Hacini; Kamel Laribi; Sébastien Bailly; Thibaut Belmondo; Marie Maerevoet; Loic Ysebaert; Stephanie Guidez; Steven Le Gouill; Christophe Bonnet; Marc André; Jehan Dupuis; Catherine Thieblemont; Emmanuel Bachy; Nicolas Daguindau; Franck Morschhauser; Sabine Tricot; Charline Moulin; Anne Banos; Roch Houot; Adrien Chauchet; Emmanuel Gyan; Guillaume Cartron; Hassan Farhat; Vincent Camus; Bernard Drenou; Hacene Zerazhi; David Sibon; Emmanuelle Nicolas-Virelizier; Caroline Delette; Sylvia Snauwaert; Sarah Bailly; Richard Delarue; Sylvain Carras; Albane Ledoux-Pilon; Marie Parrens; Samuel Griolet; Philippe Gaulard; Marie-Helene Delfau-Larue; Laurence de Leval; Gandhi Laurent Damaj
errShare
errSave
Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
err2025-08-05
err0
PREAI
errT.A. Eyre; K. Cwynarski; F. d'Amore; L. de Leval; M. Dreyling; D.A. Eichenauer; A.J.M. Ferreri; E. Giné; M.J. Kersten; M. Ladetto; L. Specht; C. Thieblemont; J. Walewski; E. Zucca; M. Jerkeman
errShare
errSave
Allogeneic Stem Cell Transplantation in Participants With Hematologic Malignancies Following Pembrolizumab Therapy
err2025-06-01
err0
PREAI
errJohn Kuruvilla; Philippe Armand; Alex F. Herrera; Vincent Ribrag; Catherine Thieblemont; Bastian von Tresckow; Guoqing Wang; Patricia Marinello; Samhita Chakraborty; Robert Orlowski; Pier Luigi Zinzani
errShare
errSave
Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition
err2025-05-21
err0
errOAAI
errSaidy, Anna Ossami; Peczynski, Christophe; Thieblemont, Catherine; Daskalakis, Michael; Wehrli, Marc; Beauvais, David; Finke, Juergen; Schorb, Elisabeth; Vandenberghe, Peter; Berning, Philipp; Stelljes, Matthias; Ayuk, Francis; Ram, Ron; Von Bonin, Malte; Dreger, Peter; Bethge, Wolfgang; Kuhnl, Andrea; Jost, Lasse; Stoelzel, Friedrich; von Tresckow, Bastian; Renner, Christoph; Fuhrmann, Stephan; Galimard, Jacques-Emmanuelle; Michel, Eva; Bazarbachi, Ali; Balari, Anna Sureda; Schmitz, Norbert; Glass, Bertram
errShare
errSave
TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas
err2025-05-05
err0
errOAAI
errPierre Stephan; Roberta Di Blasi; Louise Roulin; Jean Galtier; Julien Calvani; Véronique Meignin; Marie Donzel; Alexandra Traverse-Glehen; Elsa Poullot; Marie Parrens; Vivien Dupont; Alexandra Marquet; Steven Le Gouill; Roch Houot; Francois-Xavier Gros; François Lemonnier; Emmanuel Bachy; Catherine Thieblemont; Pierre Sesques
errShare
errSave
Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma
err2025-05-01
err0
PREAI
errLauer, U. M.; Awada, A.; Postel-Vinay, S.; Shapiro, G. I.; Thieblemont, C.; Piha-Paul, S. A.; Paik, P. K.; Shepard, D. R.; Docampo, L. I.; Galot, R.; Rottey, S.; Sadrolhefazi, B.; Marzin, K.; Musa, H.; Schoffski, P.
errShare
errSave
T cell malignancies after CAR T cell therapy in the DESCAR-T registry (vol 31, pg 1130, 2025)
err2025-04-25
err0
PREAI
errDulery, Remy; Guiraud, Vincent; Choquet, Sylvain; Thieblemont, Catherine; Bachy, Emmanuel; Barete, Stephane; Todesco, Eve; Arnulf, Bertrand; Boissel, Nicolas; Baruchel, Andre; Bay, Jacques-Olivier; Le Gouill, Steven; Houot, Roch
errShare
errSave
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study
err2025-04-03
err0
PREAI
errCartron, Guillaume; Houot, Roch; Al Tabaa, Yassine; Le Bras, Fabien; Ysebaert, Loic; Choquet, Sylvain; Jardin, Fabrice; Bay, Jacques-Olivier; Gros, Francois-Xavier; Morschhauser, Franck; Casasnovas, Olivier; Gastinne, Thomas; Thieblemont, Catherine; Joris, Magalie; Ricard, Laure; Regny, Caroline; La Rochelle, Laurianne Drieu; Feugier, Pierre; Marcais, Ambroise; Griolet, Samuel; Laurent, Camille; Sesques, Pierre
errShare
errSave
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study (vol 109, pg 2297, 2024)
err2025-04-01
err0
errOAAI
errIannitto, Emilio; Ferrero, Simone; Bommier, Come; Drandi, Daniela; Ferrante, Martina; Bouabdallah, Krimo; Carras, Sylvain; Gini, Guido; Camus, Vincent; Mancuso, Salvatrice; Marcheselli, Luigi; Ferrari, Angela; Merli, Michele; Tessoulin, Benoit; Stelitano, Caterina; Beldjord, Kheira; Roti, Giovanni; Jardin, Fabrice; Castagnari, Barbara; Palombi, Francesca; Baseggio, Lucile; Traverse-Glehen, Alexandra; Tripodo, Claudio; Liberati, Anna Marina; Parolini, Margherita; Usai, Sara; Patti, Caterina; Federico, Massimo; Musso, Maurizio; Ladetto, Marco; Zucca, Emanuele; Thieblemont, Catherine
errShare
errSave
Efficacy of tazemetostat in combination with R-CHOP in elderly patients newly diagnosed with diffuse large B cell lymphoma: results of the EpiRCHOP phase II study of the LYSA
err2025-04-01
err0
PREAI
errSarkozy, Clementine; Molina, Thierry Jo; Dubois, Sydney; Portugues, Cedric; Bohers, Elodie; Ysebaert, Loic; Houot, Roch; Pica, Gian Matteo; Ruminy, Philippe; Herbaux, Charles; Gastinne, Thomas; Thieblemont, Catherine; Haioun, Corinne; Guidez, Stephanie; Bonnet, Christophe; Crochet, Gilles; Veresezan, Liana; Choquet, Sylvain; Bachy, Emmanuel; Jardin, Fabrice; Morschhauser, Franck; Ribrag, Vincent
errShare
errSave
Lymphodepletion chemotherapy in chimeric antigen receptor-engineered T (CAR-T) cell therapy in lymphoma
err2025-03-27
err0
errOAAI
errCanelo-Vilaseca, Marta; Sabbah, Mohamad; Di Blasi, Roberta; Cristinelli, Caterina; Sureda, Anna; Caillat-Zucman, Sophie; Thieblemont, Catherine
errShare
errSave
Fatty Acid Metabolism Provides an Essential Survival Signal in OxPhos and BCR DLBCL Cells
err2025-03-13
err0
errOAAI
errMontagne, Aurelie; Kotta, Konstantina; Kielbassa-Elkadi, Karoline; Martins, Isabelle; Martinez-Climent, Jose angel; Kroemer, Guido; Thieblemont, Catherine; Baud, Veronique
errShare
errSave
TP53 Mutations Detected by NGS Are a Major Clinical Risk Factor for Stratifying Mantle Cell Lymphoma
err2025-03-06
err0
PREAI
errLazarian, G; Chemali, L; Bensalah, M; Zindel, C; Lefebvre, V; Thieblemont, C; Martin, A; Tueur, G; Letestu, R; Fleury, C; Leymarie, V; Vidal, V; Bidet, A; Maitre, E; Cymbalista, F; Levy, V; Soussi, T; Baran-Marszak, F
errShare
errSave